BioSpace News Archive

Drug Development

Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNFα Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease

Latest real-world data presented at UEG Week 2019 complements the extensive body of clinical evidence for the gut-selective biologic vedolizumab in biologic-naïve patients with moderately to severely active ulcerative colitis or Crohn’s disease

October 21, 2019
·
14 min read
Business

BIOLASE Announces Select Preliminary Third Quarter 2019 Financial Results And Date For Reporting Third Quarter 2019 Results

BIOLASE, Inc., the global leader in dental lasers, announced select unaudited preliminary financial results for the third quarter ended September 30, 2019.

October 21, 2019
·
5 min read
Business

Bruker Announces Date and Time of Third Quarter 2019 Earnings Release and Webcast

Bruker Corporation announced it will report third quarter 2019 financial results on Thursday, October 31, 2019, after the market closes.

October 21, 2019
·
1 min read
Business

Alkermes Announces Clinical Collaboration With Fred Hutchinson Cancer Research Center for Novel Immuno-Oncology Drug Candidate ALKS 4230

Planned Phase 2 Multi-Site Trial to Evaluate ALKS 4230 in Combination With Pembrolizumab in Patients With Advanced or Recurrent Head and Neck Squamous Cell Cancer

October 21, 2019
·
6 min read
Business

SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors

SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, announced the appointment of John T. Potts, MD, DSc, to its Board of Directors.

October 21, 2019
·
3 min read
Business

Rheos Medicines Appoints Barbara S. Fox as Chief Executive Officer

Rheos Medicines, a biopharmaceutical company harnessing insights in immunometabolism to create a new class of therapeutics for patients with severe autoimmune disorders, inflammatory diseases and cancer, announced the appointment of industry veteran Barbara S. Fox, Ph.D., to Chief Executive Officer.

October 21, 2019
·
3 min read
Business

Orthofix Schedules Third Quarter 2019 Earnings Release and Conference Call for October 28, 2019

Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that it plans to release financial results for the third quarter 2019 after market close on Monday, October 28, 2019.

October 21, 2019
·
1 min read
FDA

FARXIGA Approved in the US to Reduce the Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes

AstraZeneca announced that the US Food and Drug Administration has approved FARXIGA to reduce the risk of hospitalization for heart failure in adults with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors.

October 21, 2019
·
7 min read
Genetown

Goldfinch Bio Presents Methods to Mitigate Batch Effects in Whole Genome Sequencing Samples at ASHG 2019 Annual Meeting

Data-driven approach enables well-calibrated dataset for case-control genome-wide association study in the Kidney Genome Atlas

October 21, 2019
·
4 min read
Biotech Bay

VIVUS to Highlight Integrated Approach to More Effective Weight Management in Panel Discussion at the Cleveland Clinic 2019 Medical Innovation Summit

VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, announced today that John Amos, Chief Executive Officer, will participate in a panel discussion at the Cleveland Clinic 2019 Medical Innovation Summit, which is taking place October 21 – 23 in Cleveland.

October 21, 2019
·
4 min read